The objective of the study is to evaluate the efficacy of Estradiol patch compared to
placebo, as add-on to anti-psychotics in the treatment of women 38 and older with
schizophrenia, schizoaffective or schizophreniform disorder.
Phase:
Phase 3
Details
Lead Sponsor:
CliniRx Tangent Research Tangent Data
Collaborators:
MediStat Ltd. PCI pharma services (formerly BIOTEC SERVICES INTERNATIONAL LIMITED) S.C. IMUNOTEHNOMED S.R.L. Stanley Medical Research Institute Tangent Data Srl